InvestorsHub Logo
Followers 261
Posts 19732
Boards Moderated 0
Alias Born 10/03/2004

Re: Smooth post# 20139

Friday, 04/03/2009 12:42:05 AM

Friday, April 03, 2009 12:42:05 AM

Post# of 146201
>>And how many products do we presently have in animal testing now?

Presently testing--HIV, Rabies, EKC/Herpes. Scheduled or in testing--Ebola, Dengue, Flu/AviFlu.

>>How many do we think are in round two?

In round 2--HIV, Rabies, EKC/Herpes. We think also--Ebola, AviFlu. Ebola may be back in round 1 if the current testing is with a significantly altered version.

>>What's involved in completing a tox package?

Since the drug has never been tried on Humans before, the IND approval will be based entirely on the total results in animal testing. So, since so far test animals haven't shown reactions at therapeutic levels in the histological exams, pretty much increasing the dosage until 1) counter indications occur such as rashes, lesions, weight loss, loss of appetite, etc; and, 2) they begin to die. The test subjects will also be examined for other toxicity factors such as tissue damage, carcinomas, etc. Each test will run about a month plus data evaluation. Could be 1 test or could be 4 or more tests. It all depends on how the nanoviricide is classified. Considering its composition my best guess is it will be classified with monoclonals. That would be a fairly rapid tox workup.



doc.feelgoode@yahoo.com

"It ain't what they call you, it's what you answer to." --WC Fields


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News